Premium
Towards safer oral immunotherapy for food allergy and allergic asthma is still increasing in prevalence
Author(s) -
Roberts G.
Publication year - 2017
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.13046
Subject(s) - omalizumab , medicine , asthma , copd , allergy , immunoglobulin e , immunology , basophil , placebo , allergen immunotherapy , adverse effect , food allergy , eosinophil , clinical trial , randomized controlled trial , allergen , antibody , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom